Open Access
New agents to treat lower urinary tract and pelvic floor disorders
Author(s) -
Cornelius Kelleher
Publication year - 2013
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.1615
Subject(s) - mirabegron , overactive bladder , medicine , pelvic floor , regimen , urinary system , urology , botulinum toxin , urinary incontinence , anesthesia , surgery , pathology , alternative medicine
For patients with overactive bladder and a suboptimal response to antimuscarinic therapy, there are several options to consider including alteration of the antimuscarinic regimen, switching to an agent with an alternate mechanism of action (i.e., mirabegron), posterior tibial nerve stimulation, or botulinum toxin. These options are summarized in this brief review.